These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 16507375)
1. An open-label, two-period, crossover study of the systemic bioavailability in healthy women of clindamycin phosphate from two vaginal cream formulations. Levinson RS; Mitan SJ; Steinmetz JI; Gattermeir DJ; Schumacher RJ; Joffrion JL Clin Ther; 2005 Dec; 27(12):1894-900. PubMed ID: 16507375 [TBL] [Abstract][Full Text] [Related]
2. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912 [TBL] [Abstract][Full Text] [Related]
3. Single-dose relative bioavailability of a new quetiapine fumarate extended-release formulation: a postprandial, randomized, open-label, two-period crossover study in healthy Uruguayan volunteers. Estevez-Carrizo FE; Parrillo S; Ercoli MC; Estevez-Parrillo FT Clin Ther; 2011 Jun; 33(6):738-45. PubMed ID: 21704238 [TBL] [Abstract][Full Text] [Related]
4. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers. Darwish M; Tempero K; Kirby M; Thompson J Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093 [TBL] [Abstract][Full Text] [Related]
5. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers. Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838 [TBL] [Abstract][Full Text] [Related]
6. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728 [TBL] [Abstract][Full Text] [Related]
7. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers. Galan-Herrera JF; Poo JL; Rosales-Sanchez O; Fuentes-Fuentes E; Cariño L; Burke-Fraga V; Namur S; Parra MG Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138 [TBL] [Abstract][Full Text] [Related]
8. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers. Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104 [TBL] [Abstract][Full Text] [Related]
9. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers. Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293 [TBL] [Abstract][Full Text] [Related]
10. Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers. Piñeyro-López A; Pineyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez Silva M; Wacksman N; Lujàn Rangel R; de Lago A; Trejo D; Gonzàlez-de la Parra M; Namur S Clin Ther; 2006 Jan; 28(1):110-5. PubMed ID: 16490584 [TBL] [Abstract][Full Text] [Related]
11. Relative bioavailability and pharmacokinetic properties of two different enteric formulations of esomeprazole in healthy Bangladeshi male volunteers: An open-label, single-dose, randomized-sequence, two-way crossover study. Ullah MA; Shams-Ud-Dowla ; Maruf AA; Azad MA; Shohag MH; Sultana R; Latif AH; Hasnat A Clin Ther; 2010 Jul; 32(7):1419-26. PubMed ID: 20678688 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic comparison of two nicotine transdermal systems, a 21-mg/24-hour patch and a 25-mg/16-hour patch: a randomized, open-label, single-dose, two-way crossover study in adult smokers. DeVeaugh-Geiss AM; Chen LH; Kotler ML; Ramsay LR; Durcan MJ Clin Ther; 2010 Jun; 32(6):1140-8. PubMed ID: 20637967 [TBL] [Abstract][Full Text] [Related]
13. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions. Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489 [TBL] [Abstract][Full Text] [Related]
14. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects. Henney HR; Shah J Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289 [TBL] [Abstract][Full Text] [Related]
15. Bioavailability of two oral formulations of azithromycin 500 mg: a randomized, open-label, two-period crossover comparison in healthy Mexican adult subjects. Piñeyro-López A; Pineyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez Silva M; Wacksman N; Rangel RL; de Lago A; González-de la Parra M; Namur S Clin Ther; 2005 Oct; 27(10):1607-11. PubMed ID: 16330296 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and bioequivalence study of clindamycin hydrochloride formulations after single-dose administration in healthy Chinese male volunteers. Li J; Wang N; Zhang ZJ; Tian Y; Tang W; Chen Y Arzneimittelforschung; 2008; 58(7):358-62. PubMed ID: 18751503 [TBL] [Abstract][Full Text] [Related]
17. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions. Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490 [TBL] [Abstract][Full Text] [Related]
18. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers. Darwish M; Chang S; Hellriegel ET Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711 [TBL] [Abstract][Full Text] [Related]
19. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers. Ahmad M; Pervaiz F Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997 [TBL] [Abstract][Full Text] [Related]
20. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects. Marier JF; Ducharme MP; DiMarco M; Di Spirito M; Morelli G; Tippabhotla SK; Badri N; Rampal A; Monif T Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]